- $1.37bn
- $1.32bn
- $163.80m
- 89
- 66
- 51
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 15.3 | 11.2 | 28.3 | 40.8 | 47 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 12.9 | 6.99 | 18.4 | 21.7 | 22.7 |
Total Current Assets | 28.3 | 18.2 | 46.7 | 62.5 | 69.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 88.6 | 70.1 | 100 | 114 | 121 |
Total Assets | 117 | 88.3 | 147 | 176 | 191 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.36 | 1.88 | 2.8 | 3.41 | 4.47 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 4.55 | 3.76 | 4.4 | 4.72 | 5.51 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Total Equity | 112 | 84.6 | 142 | 172 | 186 |
Total Liabilities & Shareholders' Equity | 117 | 88.3 | 147 | 176 | 191 |
Total Common Shares Outstanding |